Egypt launches phase 2 of covid vaccination on the elderly
London, March 5, 2021 (AltAfrica)-Health officials in Egypt have begun the second phase of a nationwide vaccination drive.
The elderly and those with underlying medical conditions, are receiving their first doses of the Oxford-Astrazeneca vaccine against the coronavirus.
There are 40 vaccination centres countrywide.
“I was expecting a mess and this did not happen at all. Everything was organized and there was a very great respect for people and comfort in procedures”, Cairo resident, Rasha Ahmed said.
Health authorities have launched a website where beneficiaries could sign up to get jabbed. So far, over 150,000 people have filled the online request.
“They should sign an approval consent letter (before getting vaccinated), then we measure the pressure, and sugar level in the blood, and review all medical reports related to the person, then a doctor explains what the vaccine is and how to get it. We also mention that the person should have the second dose after 3 months as we give people the AstraZeneca vaccine”, said Dr. Eman Mohamed, Head of New Nozha Hospital in Cairo.
The north African nation began rolling out its anti-covid-19 vaccination program in January. Shots were first given to frontline healthcare workers.
Egypt received 350,000 doses of a coronavirus vaccine developed by China National Pharmaceutical Group (Sinopharm) in two batches since December, in addition to 50,000 doses of a vaccine developed by AstraZeneca in February.
It is hoping to receive vaccines through the COVAX facility, a global initiative aimed at providing equitable distribution of vaccines, in the coming weeks.
On Feb. 24, the Egyptian Drug Authority approved Russia’s Sputnik V vaccine for emergency use. Egypt’s Prime Speed Medical Services said it had obtained the right to provide Sputnik V in Egypt in a statement to the stock exchange, without giving details.
Reuters reports that Egypt began vaccinating frontline medical staff against COVID-19 on Jan. 24 using the Chinese vaccine.